The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Apolipoprotein E polymorphism and atherosclerosis.
Abstract
The apo E locus contributes to determining the variation in plasma cholesterol levels of healthy and diseased populations. It also influences the expression of hyperlipidemia and appears to modulate the susceptibility to atherosclerosis in a complex multifactorial interaction. There is evidence that the presence of apo E2 is protective, whereas that of apo E4 predisposes to coronary artery disease. The burden of proof, however, lies on future, well-designed clinical trials and prospective studies. The study of the biological significance of the apo E polymorphism in humans has emphasized the importance of gene-gene and gene-environment interactions in the pathogenesis of hyperlipidemia and atherosclerosis. The apo E polymorphism involves the coding region of the apo E gene and results in alterations of the gene product which, in turn, either directly or secondarily affect the metabolic fate of the lipoprotein particles. Rapid advances in knowledge over the last decade have provided a metabolic explanation for the observation of the opposite effects of the epsilon 4 and the epsilon 2 alleles on lipoprotein levels. Apo E2 has lower receptor binding affinity which results in delayed clearance of apo E2-bearing lipoprotein particles from plasma. Apo E4 is distributed differently from apo E3 between VLDL and HDL, is degraded more rapidly than apo E3, and may enhance the catabolism of E4-bearing particles, leading to other alterations in lipoprotein metabolism which result in elevated levels of LDL. In view of the significant opposite impacts of the epsilon 4 and the epsilon 2 alleles on plasma LDL cholesterol concentrations, it is evident that determination of the apo E phenotype will become a useful adjunct to the assessment of the cardiovascular risk profile of an individual. In addition, the relationship between the epsilon 2 allele and type III hyperlipoproteinemia provides a valuable model for the study of complex genetic interactions in the pathogenesis of hyperlipidemia. The further study of apo E and its interactions shows great promise for a deeper comprehension of the pathogenesis of atherosclerosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The critical role of APOE in lipid metabolism is underscored by evidence showing that APOE2 homozygosity can lead to Hyperlipoproteinemia type III (HLP), characterized by mixed hypercholesterolemia and hypertriglyceridemia [35–39].”
In the citing paper
“This observation, coupled with evident mixed hypercholesterolemia and hypertriglyceridemia, supports the characterization of APOE2hAβ rats as a model for type III HLP”
In the citing paper
“Both the ε2 and the ε4 alleles are associated with unfavorable lipid profiles [8][9][10][11][12][13].”
From APOE and vascular disease: Sequencing and genotyping in general population cohorts (2023) · cites this paper as [13]
In the citing paper
“It is estimated that less than one in 20 individuals with the ε22 genotype will have overt type III hyperlipoproteinemia [24].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [24]
In the citing paper
“At the level of an individual the effect of the APOE polymorphism on plasma lipid levels is moderate, however since the APOE polymorphism is common, it contributes substantially to the total phenotypic variability in plasma lipid levels in the general population [21,24,58].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [24]
In the citing paper
“The pattern of associations between the six common APOE genotypes and plasma lipid levels is similar across populations, although the magnitude of the associations differs between populations and subgroups within populations; thus both context-dependent and invariant associations could be suggested [9,24,30].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [24]
In the citing paper
“Both ɛ2 and ɛ4 alleles are associated with unfavourable lipid profiles,12–19”
From Plasma levels of apolipoprotein E, APOE genotype, and all-cause and cause-specific mortality in 105 949 individuals from a white general population cohort (2019) · cites this paper as [18]
In the citing paper
“a decreased risk of coronary artery disease (unless it is associated with type III hyperlipoproteinemia), 42,43”
From Preclinical Evidence of Alzheimer's Disease in Persons Homozygous for the ε4 Allele for Apolipoprotein E (1996) · cites this paper as [42]
Citations
Cites
Boyles, J. K., Pitas, R. E., Wilson, E., Mahley, R. W., & Taylor, J. M. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112130 · Cited by 829
Weisgraber, K. H., Rall, S. C., & Mahley, R. W. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52510-8 · Cited by 777
Lipoprotein receptors and cholesterol homeostasis
Mahley, R. W., & Innerarity, T. L. (1983) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(83)90001-1 · Cited by 756
Human apolipoprotein E. The complete amino acid sequence
Rall, S. C., Weisgraber, K. H., & Mahley, R. W. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34702-1 · Cited by 741
(1985) · PubMed · Cited by 706
Self-citationPolymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man
UTERMANN, G., HEES, M., & STEINMETZ, A. (1977) · Nature · doi:10.1038/269604a0 · Cited by 666
Zannis, V. I., & Breslow, J. L. (1981) · Biochemistry · doi:10.1021/bi00507a059 · Cited by 563
Polymorphism of apolipoprotein E
Utermann, G., Vogelberg, K. H., Steinmetz, A., Schoenborn, W., Pruin, N., Jaeschke, M., Hees, M. T. I. W. S.-V., & Canzler, H. (1979) · Clinical Genetics · doi:10.1111/j.1399-0004.1979.tb02027.x · Cited by 408
Apolipoprotein E polymorphism in health and disease
Utermann, G. (1987) · American Heart Journal · doi:10.1016/0002-8703(87)90610-7 · Cited by 389
Elshourbagy, N. A., Liao, W. S., Mahley, R. W., & Taylor, J. M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.1.203 · Cited by 376
Flagged first, then by citations
Cited by
Sorted by citations
Items 601–700 of 1,005
Yamauchi, K., Tozuka, M., Nakabayashi, T., Sugano, M., Hidaka, H., Kondo, Y., & Katsuyama, T. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.4.497 · Cited by 50
A synthetic peptide mimic of plasma apolipoprotein E that binds the LDL receptor.
Dyer, C. A., & Curtiss, L. K. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54425-2 · Cited by 50
Apolipoprotein E2, renal failure and lipid abnormalities in non-insulin-dependent diabetes mellitus
Horita, K., Eto, M., & Makino, I. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90021-3 · Cited by 50
Czech, C., Förstl, H., Hentschel, F., Mönning, U., Besthorn, C., Geiger-Kabisch, C., Sattel, H. C., Masters, C. L., & Beyreuther, K. T. (1994) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02191587 · Cited by 50
Friday, K. E., Srinivasan, S. R., Elkasabany, A., Dong, C., Wattigney, W. A., Dalferes, E. R., & Berenson, G. S. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90175-0 · Cited by 50
Underexpression of the apolipoprotein E4 isoform in an Italian population.
James, R. W., Boemi, M., Giansanti, R., Fumelli, P., & Pometta, D. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.10.1456 · Cited by 50
Zerba, K. E., Ferrell, R. E., & Sing, C. F. (2000) · Human Genetics · doi:10.1007/s004390000394 · Cited by 49
Self-citationOh, J., & Barrett-Connor, E. L. (2001) · Clinical Genetics · doi:10.1034/j.1399-0004.2001.600207.x · Cited by 49
Navarro, S., Cubiella, J., Feu, F., Zambón, D., Fernández‐Cruz, L., & Ros, E. (2004) · Medicina Clínica · doi:10.1016/s0025-7753(04)74599-6 · Cited by 49
Fazio, S., Sanan, D. A., Lee, Y. L., Ji, Z. S., Mahley, R. W., & Rall, S. C. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.11.1873 · Cited by 49
TREATMENT OF HYPERLIPIDEMIA IN RENAL TRANSPLANT RECIPIENTS1
Árnadóttir, M., & Berg, A. (1997) · Transplantation · doi:10.1097/00007890-199702150-00002 · Cited by 49
Friedlander, Y., Leitersdorf, E., Vecsler, R., Funke, H., & Kark, J. D. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00474-8 · Cited by 49
Relevance of Apolipoprotein E Polymorphism for Coronary Artery Disease in the Saudi Population
Dzimiri, N., Meyer, B. F., Hussain, S. S., Basco, C., Afrane, B. A., & Al‐Halees, Z. (1999) · Archives of Pathology & Laboratory Medicine · doi:10.5858/1999-123-1241-roaepf · Cited by 49
Berglund, L., Wiklund, O., Eggertsen, G., Olofsson, S. ‐., Eriksson, M., LINDÉN, T., Bondjers, G., & Angelin, B. (1993) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1993.tb00670.x · Cited by 49
Association between apolipoprotein E gene polymorphism and depression
Feng, F., Lu, S.-S., Hu, C.-Y., Gong, F.-F., Qian, Z.-Z., Yang, H.-Y., Wu, Y.-L., Zhao, Y.-Y., Bi, P., & Sun, Y.-H. (2015) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2015.02.012 · Cited by 51
Zhang, M., Gu, W., Qiao, S.-B., Zhu, E., Zhao, Q., & Lv, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095463 · Cited by 49
Sánchez-Muniz, F. J., Maki, K. C., Schaefer, E. J., & Ordovás, J. M. (2008) · Journal of Nutrition · doi:10.3945/jn.108.090969 · Cited by 48
Mendivil, C. O., Rimm, E. B., Furtado, J., & Sacks, F. M. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000130 · Cited by 48
Sparks, D. L., Scheff, S. W., Liu, H., Landers, T. M., Danner, F., Coyne, C. M., & Hunsaker, J. C. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(96)00008-1 · Cited by 48
Lee, Y. J., Park, D., Kim, S. Y., & Park, W. J. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.8.629 · Cited by 48
Corbo, R. M., Vilardo, T., Ruggeri, M., Gemma, A. T., & Scacchi, R. (1999) · Clinical Biochemistry · doi:10.1016/s0009-9120(99)00011-9 · Cited by 48
Apo E variants in patients with type III hyperlipoproteinemia
Civeira, F., Pocoví, M., Cenarro, A., Casao, E., Vilella, E., Joven, J., González, J., Garcia-Otín, A. L., & Ordovás, J. (1996) · Atherosclerosis · doi:10.1016/s0021-9150(96)05969-2 · Cited by 48
Genetic Determinants of Arterial Calcification Associated With Atherosclerosis
Doherty, T. M., Fitzpatrick, L. A., Shaheen, A., Rajavashisth, T. B., & Detrano, R. (2004) · Mayo Clinic Proceedings · doi:10.4065/79.2.197 · Cited by 49
apoE4 allele and the natural history of cardiovascular risk factors
Scuteri, A., Najjar, S. S., Muller, D. C., Andres, R., Morrell, C. H., Zonderman, A. B., & Lakatta, E. G. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00408.2004 · Cited by 48
Apolipoprotein E and longevity among Han Chinese population
Jian-gang, Z., Ma, Y., Chuan-Fu, W., Pei-Fang, L., Song-Bai, Z., Nui-Fan, G., Feng, G., & He, L. (1998) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(98)00067-0 · Cited by 48
Bader, G., Zuliani, G., Kostner, G. M., & Fellin, R. (1998) · Gerontology · doi:10.1159/000022030 · Cited by 48
Watts, G. F., Cummings, M. H., Umpleby, A. M., Quiney, J., Naoumova, R. P., Thompson, G. R., & Sönksen, P. H. (1995) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1995.tb01746.x · Cited by 48
Kardia, S. L. R., Haviland, M. B., Ferrell, R. E., & Sing, C. F. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.2.427 · Cited by 48
Self-citationApolipoprotein E and familial longevity
Schupf, N., Barral, S., Perls, T. T., Newman, A. B., Christensen, K., Thyagarajan, B., Province, M. A., Rossi, W. K., & Mayeux, R. P. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.08.019 · Cited by 47
Rasmussen‐Torvik, L. J., Pacheco, J. A., Wilke, R. A., Thompson, W. K., Ritchie, M. D., Kho, A., Muthalagu, A., Hayes, M. G., Armstrong, L. L., Scheftner, D. A., et al. (2012) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2012.00446.x · Cited by 47
Haplotype analysis of APOE intragenic SNPs
Babenko, V. N., Afonnikov, D. A., Ignatieva, E. V., Klimov, A. V., Gusev, F. E., & Rogaev, E. I. (2018) · BMC Neuroscience · doi:10.1186/s12868-018-0413-4 · Cited by 47
From beta amyloid to altered proteostasis in Alzheimer’s disease
Bruni, A. C., Bernardi, L., & Gabelli, C. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101126 · Cited by 47
Beilby, J. P., Hunt, C., Palmer, L. J., Chapman, C., Burley, J. P., McQuillan, B., Thompson, P. L., & Hung, J. (2003) · Stroke · doi:10.1161/01.str.0000062901.54157.12 · Cited by 47
Hu‐Lince, D., Craig, D. W., Huentelman, M. J., & Stephan, D. A. (2005) · American Journal of PharmacoGenomics · doi:10.2165/00129785-200505040-00004 · Cited by 48
APOE polymorphism and the hypertriglyceridemic effect of dietary sucrose
Erkkilä, A. T., Sarkkinen, E. S., Lindi, V., Lehto, S., Laakso, M., & Uusitupa, M. I. J. (2001) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.4.746 · Cited by 47
Cholesterol efflux as a critical component of Alzheimer’s disease pathogenesis
Rebeck, G. (2007) · Journal of Molecular Neuroscience · doi:10.1385/jmn:23:3:219 · Cited by 47
Rao, V. S., Cupples, L. A., van Duijn, C. M., Kurz, A., Green, R. C., Chui, H. C., Duara, R., Auerbach, S. H., Volicer, L., Wells, J., et al. (1996) · PubMed Central · Cited by 47
Hubacek, J. A., Pitha, J. V., Škodová, Z., Poledne, R., Lánská, V., Waterworth, D. M., Humphries, S. E., & Talmud, P. J. (2003) · Clinical Biochemistry · doi:10.1016/s0009-9120(03)00025-0 · Cited by 46
Moreno, J. A., López‐Miranda, J., Marı́n, C., Gómez, P., Pérez‐Martínez, P., Fuentes, F. J., de la Puebla, R. Á. F., Paniagua, J. A., Ordovás, J. M., & Pérez‐Jiménez, F. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300124-jlr200 · Cited by 46
Harmful Effects of Increased LDLR Expression in Mice With Human APOE*4 But Not APOE*3
Malloy, S. I., Altenburg, M. K., Knouff, C., Lanningham-Foster, L., Parks, J. S., & Maeda, N. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000094963.07902.fb · Cited by 37
Apolipoprotein E: Depressive illness, depressive symptoms, and Alzheimer's disease
Holmes, C., Russ, C., Kirov, G., Aitchison, K. J., Powell, J. F., Collier, D. A., & Lovestone, S. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00326-0 · Cited by 46
Cholesterol and apolipoprotein E in Alzheimer's disease
Reiss, A. B. (2005) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331750502000208 · Cited by 46
Naidu, A., Xu, Q., Catalano, R., & Cordell, B. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03480-7 · Cited by 46
Association of apolipoprotein E allele ϵ4 with late‐onset sporadic Alzheimer's disease
Lucotte, G., Visvikis‐Siest, S., Leininger‐Muller, B., David, F., Berriche, S., Réveilleau, S., Couderc, R., Babron, M., Aguillon, D., & Siest, G. (1994) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320540319 · Cited by 46
Apolipoprotein E Polymorphism and LDL Size in a Biethnic Population
Haffner, S. M., Stern, M. P., Miettinen, H., Robbins, D. C., & Howard, B. V. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.9.1184 · Cited by 46
Causes of high blood cholesterol.
Grundy, S. M., & Vega, G. L. (1990) · Circulation · doi:10.1161/01.cir.81.2.412 · Cited by 46
GENETIC COMPONENTS OF VARIATION IN ENERGY STORAGE IN DROSOPHILA MELANOGASTER
Clark, A. G. (1990) · Evolution · doi:10.1111/j.1558-5646.1990.tb05944.x · Cited by 46
Persson, N., Ghisletta, P., Dahle, C. L., Bender, A. R., Yang, Y., Yuan, P., Daugherty, A. M., & Raz, N. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2014.09.042 · Cited by 45
Function and Comorbidities of Apolipoprotein E in Alzheimer′s Disease
Leduc, V., Domenger, D., Beaumont, L. D., Lalonde, D., Jasmin, S. B., & Poirier, J. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/974361 · Cited by 46
APOE E4 is a determinant for Alzheimer type pathology in progressive supranuclear palsy
Tsuboi, Y., Josephs, K. A., Cookson, N., & Dickson, D. W. (2003) · Neurology · doi:10.1212/01.wnl.0000044340.37138.a9 · Cited by 45
Meigs, J. B., Ordovás, J. M., Cupples, L. A., Singer, D. E., Nathan, D. M., Schaefer, E. J., & Wilson, P. W. (2000) · Diabetes Care · doi:10.2337/diacare.23.5.669 · Cited by 45
Apolipoprotein E4 association with metabolic syndrome depends on body fatness
Torres-Pérez, E., Ledesma, M., García-Sobreviela, M. P., León-Latre, M., & Arbonés-Mainar, J. M. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.11.029 · Cited by 45
Graves, A. B., Rajaram, L., Bowen, J. D., McCormick, W. C., McCurry, S. M., & Larson, E. B. (1999) · The Journals of Gerontology Series B · doi:10.1093/geronb/54b.3.s154 · Cited by 46
LPL polymorphism predicts stroke risk in men
Morrison, A. C., Ballantyne, C. M., Bray, M. S., Chambless, L. E., Sharrett, A. R., & Boerwinkle, E. (2002) · Genetic Epidemiology · doi:10.1002/gepi.0191 · Cited by 45
Boizel, R., Benhamou, P., Corticelli, P., Valenti, K., Bosson, J.-L., & Halimi, S. (1998) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/13.1.72 · Cited by 45
Contois, J. H., Anamani, D. E., & Tsongalis, G. J. (1996) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(18)30290-7 · Cited by 45
Burman, D., Mente, A., Hegele, R. A., Islam, S., Yusuf, S., & Anand, S. S. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.06.007 · Cited by 44
González, H. M., Tarraf, W., Jian, X., Vásquez, P. M., Kaplan, R. C., Thyagarajan, B., Daviglus, M. L., Lamar, M., Gallo, L. C., Zeng, D., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-35573-3 · Cited by 44
Iyengar, S. K., Hamman, R. F., Marshall, J. A., Majumder, P. P., Ferrell, R. E., Rao, D. C., & Vogler, G. P. (1989) · Genetic Epidemiology · doi:10.1002/gepi.1370060606 · Cited by 44
Paschos, G. K., Yiannakouris, N., Rallidis, L. S., Davies, I. G., Griffin, B. A., Panagiotakos, D. B., Skopouli, F. N., Votteas, V., & Zampelas, A. (2005) · Angiology · doi:10.1177/000331970505600107 · Cited by 44
Yamauchi, K., Tozuka, M., Hidaka, H., Hidaka, E., Kondo, Y., & Katsuyama, T. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.9.1431 · Cited by 41
Heterogeneity of Apolipoprotein E Polymorphism in Different Mexican Populations
Aceves, D., Ruiz, B., Nuño, P., Román, S., Zepeda-Carrillo, E. A., & Panduro, A. (2006) · Human Biology · doi:10.1353/hub.2006.0021 · Cited by 44
11. Molecular genetics of Alzheimer's disease
Hardy, J., Owen, M. J., Goate, A., James, L., Haynes, A. R., Williamson, R., Roques, P. K., Rossor, M. N., & Mullan, M. J. (1989) · Biochemical Society Transactions · doi:10.1007/978-1-4613-0513-2_3 · Cited by 44
Genetic Studies of Human Apolipoproteins
Kamboh, M. I., & Ferrell, R. E. (1990) · Human Heredity · doi:10.1159/000153931 · Cited by 44
Apolipoprotein E polymorphism in the Greek population
Sklavounou, E., Economou-Petersen, E., Karadima, G., Πάνας, Μ., Avramopoulos, D., Varsou, A., Vassilopoulos, D., & Petersen, M. B. (1997) · Clinical Genetics · doi:10.1111/j.1399-0004.1997.tb02550.x · Cited by 44
Genotypic associations of the hepatic secretion of VLDL apolipoprotein B-100 in obesity
Watts, G. F., Riches, F. M., Humphries, S. E., Talmud, P. J., & BOCKXMEER, F. M. V. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34487-4 · Cited by 44
Apolipoprotein E: A pharmacogenetic target for the treatment of Alzheimer's disease*
Poirier, J. (1999) · Molecular Diagnosis · doi:10.1016/s1084-8592(99)80010-1 · Cited by 44
Schmitz, G., Brüning, T., Kovacs, E., & Barlage, S. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.7.1053 · Cited by 44
Dallongeville, J., Roy, M., LeBoeuf, N. R., Xhignesse, M., Davignon, J., & Lussier‐Cacan, S. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.2.272 · Cited by 44
Self-citationGenetic Epidemiology of Alzheimer Disease
Slooter, A. J. C., & van Duijn, C. M. (1997) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a017933 · Cited by 44
Karjalainen, J.-P., Mononen, N., Hutri‐Kähönen, N., Lehtimäki, M., Hilvo, M., Kauhanen, D., Juonala, M., Viikari, J. S. A., Kähönen, M. A. P., Raitakari, O. T., et al. (2019) · Journal of Lipid Research · doi:10.1194/jlr.m092809 · Cited by 43
Durliat, M., André, M., & Babin, P. J. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01033.x · Cited by 43
della Rovere, G. R., Lapolla, A., Sartore, G., Rossetti, C., Zambon, S., Minicuci, N., Crepaldi, G., Fedele, D., & Manzato, E. (2003) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/s0939-4753(03)80167-9 · Cited by 43
Rastas, S., Mattila, K. J., Verkkoniemi, A., Niinistö, L., Juva, K., Sulkava, R. O., & Länsimies, E. (2004) · BMC Geriatrics · doi:10.1186/1471-2318-4-1 · Cited by 43
Chen, Q. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00160-6 · Cited by 44
Couch, S. C., Cross, A. T., Kida, K., Ros, E., Plaza, I., Shea, S. A., & Deckelbaum, R. J. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.5.1266s · Cited by 43
Ellsworth, D. L., Sholinsky, P. D., Jaquish, C. E., Fabsitz, R. R., & Manolio, T. (1999) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(98)00138-x · Cited by 43
Apolipoprotein E and atherosclerosis in Alaska Natives
Scheer, W. D., Boudreau, D. A., Malcom, G. T., & Middaugh, J. P. (1995) · Atherosclerosis · doi:10.1016/0021-9150(94)05483-y · Cited by 43
Houlston, R. S., Snowden, C. P., Green, F. R., Alberti, K. G. M. M., & Humphries, S. E. (1989) · Human Genetics · doi:10.1007/bf00291382 · Cited by 43
Detection of point mutations in human genes by the solid-phase minisequencing method
Syvänen, A. (1994) · Clinica Chimica Acta · doi:10.1016/0009-8981(94)90217-8 · Cited by 43
(1993) · PubMed · Cited by 43
Pocovi, M., Cenarro, A., Civeir, F., Myers, R. H., Casao, E., Esteban, M., & Ordovas, J. M. (1996) · Atherosclerosis · doi:10.1016/0021-9150(95)06745-0 · Cited by 42
Ma, Y., Smith, C. E., Lai, C., Irvin, M. R., Parnell, L. D., Lee, Y., Pham, L. D., Aslibekyan, S. W., Claas, S. A., Tsai, M. Y., et al. (2014) · Aging Cell · doi:10.1111/acel.12293 · Cited by 42
Xiying, M., Wu, W., Fang, W., & Qing-huai, L. (2017) · Archives of Medical Research · doi:10.1016/j.arcmed.2017.08.002 · Cited by 43
Apolipoprotein E polymorphism affects carotid artery atherosclerosis in smoking hypertensive men
Karvonen, J., Kauma, H., Kervinen, K., Ukkola, O. H., Rantala, M., Päivänsalo, M. J., Savolainen, M. J., & Kesäniemi, Y. A. (2002) · Journal of Hypertension · doi:10.1097/00004872-200212000-00015 · Cited by 42
Effect of the angiotensin I-converting enzyme I/D polymorphism on cognitive decline☆
Richard, F., Berr, C., Amant, C., Helbecque, N., Amouyel, P., & Alpérovitch, A. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00102-5 · Cited by 42
Apolipoprotein E polymorphism and serum lipid response to plant sterols in humans
Geelen, A., Zock, P. L., de Vries, J. H. M., & Katan, M. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.01061.x · Cited by 42
Sheridan, D. A., Price, D., Schmid, M. L., Toms, G. L., Donaldson, P. T., NEELY, D., & Bassendine, M. F. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04012.x · Cited by 42
Molecular genetics of myocardial infarction
Yamada, Y., Ichihara, S., & Nishida, T. (2008) · Genomic Medicine · doi:10.1007/s11568-008-9025-x · Cited by 42
Adams, M. K. M., Simpson, J. A., Richardson, A. J., English, D. R., Aung, K. Z., Makeyeva, G. A., Guymer, R. H., Giles, G. G., Hopper, J., Robman, L. D., et al. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kwr329 · Cited by 42
HOFFMANN, M. M., SCHARNAGL, H., PANAGIOTOU, E., BANGHARD, W. T., WIELAND, H., & MA[Combining Diaeresis]RZ, W. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v123524 · Cited by 42
Scacchi, R., Gambina, G., Martini, M. C., Broggio, E., Vilardo, T., & Corbo, R. M. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(02)01437-4 · Cited by 42
APOE genotype influences functional status among elderly without dementia
Albert, S. M., Gurland, B. J., Maestre, G. E., Jacobs, D. M., Stern, Y., & Mayeux, R. P. (1995) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320600621 · Cited by 42
Attila, G., Acartürk, E., Eskandari, G., Akpınar, O., Tuli, A., Kanadaşı, M., & Kayrın, L. (2001) · Clinica Chimica Acta · doi:10.1016/s0009-8981(01)00624-6 · Cited by 43
Aguilar, C. A., Talavera, G., Ordovás, J. M., Barriguete, J. A., Guillén-Pineda, L. E., Leco, M. E., Pedro‐Botet, J., González‐Barranco, J., Gómez-Pérez, F. J., & Rull, J. A. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(98)00251-2 · Cited by 42
Ionizing radiation and genetic risks
Sankaranarayanan, K., Chakraborty, R., & Boerwinkle, E. (1999) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(98)00017-9 · Cited by 42
A gene-gender interaction affecting plasma lipoproteins in a genetic isolate.
Hegele, R. A., Evans, A. J., Tu, L., Ip, G., Brunt, J., & Connelly, P. W. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.5.671 · Cited by 42
Multi-functional role of apolipoprotein E in neurodegenerative diseases
Islam, S., Noorani, A. A., Sun, Y., Michikawa, M., & Zou, K. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1535280 · Cited by 43
Apolipoprotein E Mimetics and Cholesterol-Lowering Properties
Sharifov, O. F., Nayyar, G., Garber, D. W., Handattu, S. P., Mishra, V., Goldberg, D., Anantharamaiah, G. M., & Gupta, H. (2011) · American Journal of Cardiovascular Drugs · doi:10.2165/11594190-000000000-00000 · Cited by 41
Quantification and regulation of apolipoprotein E expression in rat Kupffer cells.
Dawson, P. A., Lukaszewski, L. M., Ells, P., Malbon, C. C., & Williams, D. L. (1989) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38368-1 · Cited by 41
Metadata
- Authors
- Davignon, J., Gregg, R. E., & Sing, C. F.
- Affiliations
- Montreal Clinical Research Institute (CA)
- Venue
- Arteriosclerosis: An Official Journal of the American Heart Association, Inc.
- Published
- 1988-01
- Volume
- 8
- Issue
- 1
- Pages
- 1-21
- ISSN
- 0276-5047 (ISSN-L)
- OpenAlex
- W2066644955
- Cited by
- 1,981
- References
- 98
- Citations by year
- 2026: 10 · 2025: 7 · 2024: 17 · 2023: 10 · 2022: 9 · 2021: 21 · 2020: 21 · 2019: 21 · 2018: 27 · 2017: 28 · 2016: 23 · 2015: 33 · 2014: 31 · 2013: 40 · 2012: 49
- FWCI
- 83.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Arteriosclerosis An Official Journal of the American Heart Association Inc (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL24489, HL-39107)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- APOE polymorphism, atherosclerosis, coronary artery disease, hyperlipidemia, LDL cholesterol, lipoprotein metabolism, gene-environment interaction, type III hyperlipoproteinemia, cardiovascular risk assessment, genetic susceptibility
- MeSH terms
- Alleles, Apolipoproteins, Apolipoproteins E, Arteriosclerosis, Coronary Disease, Humans, Lipids, Lipoproteins, Phenotype, Polymorphism, Genetic, Radiography, Risk Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
